{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:58:03Z","timestamp":1768096683441,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81072641"],"award-info":[{"award-number":["81072641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81273499"],"award-info":[{"award-number":["81273499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81200096"],"award-info":[{"award-number":["81200096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science and Technology Major Project of China \u201cKey New Drug Creation and Manufacturing Program\u201d","award":["2011ZX09401-307"],"award-info":[{"award-number":["2011ZX09401-307"]}]},{"name":"Team item of Natural Science Foundation of Guangdong Province","award":["S2011030003190"],"award-info":[{"award-number":["S2011030003190"]}]},{"name":"Major Project of Guangdong Province","award":["2008A030201013"],"award-info":[{"award-number":["2008A030201013"]}]},{"name":"Major Project of Guangdong Province","award":["2012A080201007"],"award-info":[{"award-number":["2012A080201007"]}]},{"name":"Major Project of Department of Education of Guangdong Province","award":["CXZD1006"],"award-info":[{"award-number":["CXZD1006"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bbrc.2014.01.045","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T14:15:52Z","timestamp":1390400152000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1"],"prefix":"10.1016","volume":"444","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiantao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaorui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luankun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongbao","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5433-0302","authenticated-orcid":false,"given":"Peiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.01.045_b0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2014.01.045_b0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1527-3466.2007.00018.x","article-title":"Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors","volume":"25","author":"Pacher","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.bbrc.2014.01.045_b0015","doi-asserted-by":"crossref","first-page":"H1545","DOI":"10.1152\/ajpheart.01124.2005","article-title":"Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy","volume":"291","author":"Pillai","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2014.01.045_b0020","doi-asserted-by":"crossref","first-page":"43121","DOI":"10.1074\/jbc.M506162200","article-title":"Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity","volume":"280","author":"Pillai","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.01.045_b0025","doi-asserted-by":"crossref","first-page":"H486","DOI":"10.1152\/ajpheart.00437.2004","article-title":"Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure","volume":"288","author":"Pillai","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2014.01.045_b0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bies.20085","article-title":"The PARP superfamily","volume":"26","author":"Ame","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.bbrc.2014.01.045_b0035","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bbrc.2012.11.132","article-title":"PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1","volume":"430","author":"Geng","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.01.045_b0040","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0006-291X(03)01483-9","article-title":"NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes","volume":"308","author":"Ying","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.01.045_b0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/bjc.2011.382","article-title":"The role of PARP in DNA repair and its therapeutic exploitation","volume":"105","author":"Javle","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2014.01.045_b0050","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway","volume":"285","author":"Pillai","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2014.01.045_b0055","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/pmic.201000482","article-title":"Clarifying the signal network of salvianolic acid B using proteomic assay and bioinformatic analysis","volume":"11","author":"Feng","year":"2011","journal-title":"Proteomics"},{"key":"10.1016\/j.bbrc.2014.01.045_b0060","doi-asserted-by":"crossref","first-page":"e59621","DOI":"10.1371\/journal.pone.0059621","article-title":"Salvianolic acid A, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2014.01.045_b0065","doi-asserted-by":"crossref","first-page":"508938","DOI":"10.1155\/2012\/508938","article-title":"Cardioprotective effects of salvianolic acid a on myocardial ischemia-reperfusion injury in vivo and in vitro","volume":"2012","author":"Fan","year":"2012","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.bbrc.2014.01.045_b0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/FJC.0b013e31822de355","article-title":"Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia\/reperfusion injury","volume":"58","author":"Pan","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.01.045_b0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fphar.2010.00111","article-title":"Magnesium lithospermate B protects cardiomyocytes from ischemic injury via inhibition of TAB1-p38 apoptosis signaling","volume":"1","author":"Du","year":"2010","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2014.01.045_b0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10616-006-6334-6","article-title":"An optimized protocol for culture of cardiomyocyte from neonatal rat","volume":"49","author":"Fu","year":"2005","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bbrc.2014.01.045_b0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/BJ20101484","article-title":"Ca2+-induced PARP-1 activation and ANF expression are coupled events in cardiomyocytes","volume":"438","author":"Geistrikh","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2014.01.045_b0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.trsl.2007.11.005","article-title":"Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis","volume":"151","author":"Gao","year":"2008","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbrc.2014.01.045_b0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ab.2003.11.015","article-title":"An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors","volume":"326","author":"Putt","year":"2004","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2014.01.045_b0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tox.2007.12.020","article-title":"Benzo[a]pyrene-induced necrosis in the HepG(2) cells via PARP-1 activation and NAD(+) depletion","volume":"245","author":"Lin","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.bbrc.2014.01.045_b0105","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.febslet.2012.02.014","article-title":"Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6","volume":"586","author":"Cai","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2014.01.045_b0110","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.bbadis.2013.07.003","article-title":"Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease","volume":"1832","author":"Sergeeva","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2014.01.045_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1423-0127-18-30","article-title":"Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection","volume":"18","author":"Ho","year":"2011","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrc.2014.01.045_b0120","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0008-6363(99)00145-5","article-title":"The renin-angiotensin system and experimental heart failure","volume":"43","author":"Wollert","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrc.2014.01.045_b0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1753944710396538","article-title":"Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways","volume":"5","author":"Pan","year":"2011","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.bbrc.2014.01.045_b0130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","article-title":"Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors","volume":"4","author":"Jagtap","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2014.01.045_b0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1179\/1351000212Y.0000000001","article-title":"NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns","volume":"17","author":"Massudi","year":"2012","journal-title":"Redox Rep."},{"key":"10.1016\/j.bbrc.2014.01.045_b0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.toxlet.2012.11.023","article-title":"Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K\/Akt signal pathway","volume":"216","author":"Wang","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrc.2014.01.045_b0145","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.yjmcc.2010.12.018","article-title":"Regulation of myocardial growth and death by NADPH oxidase","volume":"50","author":"Maejima","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2014.01.045_b0150","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.freeradbiomed.2012.07.010","article-title":"Oxidative and nitrosative stress in the maintenance of myocardial function","volume":"53","author":"Zhang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2014.01.045_b0155","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbrc.2010.05.019","article-title":"Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells","volume":"396","author":"Manea","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2014.01.045_b0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jcb.20567","article-title":"Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells","volume":"96","author":"Zhou","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2014.01.045_b0165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcb.1176","article-title":"Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells","volume":"82","author":"Chen","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2014.01.045_b0170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.phrs.2007.01.016","article-title":"Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan","volume":"55","author":"Wang","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2014.01.045_b0175","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.cjca.2013.04.026","article-title":"Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression","volume":"29","author":"Zeng","year":"2013","journal-title":"Can. J. Cardiol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T01:55:02Z","timestamp":1538877302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0006291X14000692"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.045","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}